Pesquisa | BVS Violência e Saúde

1.

The Next Phase of Human Gene-Therapy Oversight.

Collins, Francis S; Gottlieb, Scott.

N Engl J Med ; 380(4): 402, 2019 01 24.

Artigo em Inglês | MEDLINE | ID: mdl-30673550

2.

Balancing Safety and Innovation for Cell-Based Regenerative Medicine.

Marks, Peter; Gottlieb, Scott.

N Engl J Med ; 378(10): 954-959, 2018 03 08.

Artigo em Inglês | MEDLINE | ID: mdl-29514023

3.

The Next Phase of Human Gene-Therapy Oversight.

Collins, Francis S; Gottlieb, Scott.

N Engl J Med ; 379(15): 1393-1395, 2018 Oct 11.

Artigo em Inglês | MEDLINE | ID: mdl-30110242

4.

The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance.

Throckmorton, Douglas C; Gottlieb, Scott; Woodcock, Janet.

N Engl J Med ; 379(3): 205-207, 2018 Jul 19.

Artigo em Inglês | MEDLINE | ID: mdl-29847203

5.

A Nicotine-Focused Framework for Public Health.

Gottlieb, Scott; Zeller, Mitchell.

N Engl J Med ; 377(12): 1111-1114, 2017 Sep 21.

Artigo em Inglês | MEDLINE | ID: mdl-28813211

6.

Pot Legalization Makes Vaping Deadly.

Gottlieb, Scott.

Mo Med ; 117(1): 9-10, 2020.

Artigo em Inglês | MEDLINE | ID: mdl-32158031

7.

FDA Regulation of Mobile Medical Apps.

Shuren, Jeffrey; Patel, Bakul; Gottlieb, Scott.

JAMA ; 320(4): 337-338, 2018 Jul 24.

Artigo em Inglês | MEDLINE | ID: mdl-29971339

8.

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

Gottlieb, Scott; Woodcock, Janet.

JAMA ; 318(5): 421-422, 2017 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-28687816

9.

Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.

Gelfand, Joel M; Shin, Daniel B; Armstrong, April W; Tyring, Stephen K; Blauvelt, Andrew; Gottlieb, Scott; Lockshin, Benjamin N; Kalb, Robert E; Fitzsimmons, Robert; Rodante, Justin; Parel, Philip; Manyak, Grigory A; Mendelsohn, Laurel; Noe, Megan H; Papadopoulos, Maryte; Syed, Maha N; Werner, Thomas J; Wan, Joy; Playford, Martin P; Alavi, Abass; Mehta, Nehal N.

JAMA Dermatol ; 158(12): 1394-1403, 2022 12 01.

Artigo em Inglês | MEDLINE | ID: mdl-36129688

10.

NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.

Zelenetz, Andrew D; Ahmed, Islah; Braud, Edward Louis; Cross, James D; Davenport-Ennis, Nancy; Dickinson, Barry D; Goldberg, Steven E; Gottlieb, Scott; Johnson, Philip E; Lyman, Gary H; Markus, Richard; Matulonis, Ursula A; Reinke, Denise; Li, Edward C; DeMartino, Jessica; Larsen, Jonathan K; Hoffman, James M.

J Natl Compr Canc Netw ; 9 Suppl 4: S1-22, 2011 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-21976013

11.

Warning: Medicare May Be Bad for Your Heart.

Gottlieb, Scott.

Mo Med ; 113(5): 407-408, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-30228509

12.

How Obama's FDA Keeps Generic Drugs Off the Market.

Gottlieb, Scott.

Mo Med ; 113(6): 444-445, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-30228523

13.

Health Costs And Financing: Challenges And Strategies For A New Administration.

Shrank, William H; DeParle, Nancy-Ann; Gottlieb, Scott; Jain, Sachin H; Orszag, Peter; Powers, Brian W; Wilensky, Gail R.

Health Aff (Millwood) ; 40(2): 235-242, 2021 02.

Artigo em Inglês | MEDLINE | ID: mdl-33476208

14.

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).

Gelfand, Joel M; Shin, Daniel B; Duffin, Kristina Callis; Armstrong, April W; Blauvelt, Andrew; Tyring, Stephen K; Menter, Alan; Gottlieb, Scott; Lockshin, Benjamin N; Simpson, Eric L; Kianifard, Farid; Sarkar, Rajendra Prasad; Muscianisi, Elisa; Steadman, Jennifer; Ahlman, Mark A; Playford, Martin P; Joshi, Aditya A; Dey, Amit K; Werner, Thomas J; Alavi, Abass; Mehta, Nehal N.

J Invest Dermatol ; 140(9): 1784-1793.e2, 2020 09.

Artigo em Inglês | MEDLINE | ID: mdl-32088207

15.

Regulatory changes needed to spur market for comparative effectiveness research.

Gottlieb, Scott.

Mod Healthc ; 44(1): 23, 2014 Jan 06.

Artigo em Inglês | MEDLINE | ID: mdl-24640395

16.

Bolstering FDA Pathways for Reducing Death and Disease from Tobacco.

Gottlieb, Scott; McClellan, Mark B.

JAMA Health Forum ; 5(4): e241233, 2024 Apr 05.

Artigo em Inglês | MEDLINE | ID: mdl-38602704

17.

Bringing Transparency and Rigor to Medicare Drug Pricing.

Gottlieb, Scott.

JAMA Health Forum ; 4(3): e230639, 2023 03 03.

Artigo em Inglês | MEDLINE | ID: mdl-36862406

18.

Strategies for Regulating Disruptive Medical Technologies.

Gottlieb, Scott.

JAMA Health Forum ; 4(12): e235460, 2023 Dec 01.

Artigo em Inglês | MEDLINE | ID: mdl-38153743

19.

Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical Practice.

Gottlieb, Scott; Silvis, Lauren.

JAMA Health Forum ; 4(6): e232300, 2023 Jun 02.

Artigo em Inglês | MEDLINE | ID: mdl-37289461

20.

How to Safely Integrate Large Language Models Into Health Care.

Gottlieb, Scott; Silvis, Lauren.

JAMA Health Forum ; 4(9): e233909, 2023 09 01.

Artigo em Inglês | MEDLINE | ID: mdl-37733359

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

The Next Phase of Human Gene-Therapy Oversight.

Balancing Safety and Innovation for Cell-Based Regenerative Medicine.

The Next Phase of Human Gene-Therapy Oversight.

The FDA and the Next Wave of Drug Abuse - Proactive Pharmacovigilance.

A Nicotine-Focused Framework for Public Health.

Pot Legalization Makes Vaping Deadly.

FDA Regulation of Mobile Medical Apps.

Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.

Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.

NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.

Warning: Medicare May Be Bad for Your Heart.

How Obama's FDA Keeps Generic Drugs Off the Market.

Health Costs And Financing: Challenges And Strategies For A New Administration.

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).

Regulatory changes needed to spur market for comparative effectiveness research.

Bolstering FDA Pathways for Reducing Death and Disease from Tobacco.

Bringing Transparency and Rigor to Medicare Drug Pricing.

Strategies for Regulating Disruptive Medical Technologies.

Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical Practice.

How to Safely Integrate Large Language Models Into Health Care.